openPR Logo
Press release

Tamoxifen Market with Industry Size, Market aspect, and Forecast 2017-2025 Acute Market Reports

01-31-2018 11:27 AM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Acute Market Reports

Tamoxifen Market with Industry Size, Market aspect,

Tamoxifen Market Growth, Future Prospects and Competitive Analysis, 2017-2025, the tamoxifen market was valued at USD 676.6 Mn in 2017, and is expected to reach USD 683.6 Mn by 2025, expanding at a CAGR of 0.07% from 2017 to 2025.

Browse Full Report: http://www.acutemarketreports.com/report/tamoxifen-market

Market Insights

Tamoxifen is the oldest and among the most prescribed selective estrogen receptor modulator for breast cancer treatment and management. Tamoxifen is approved for early stage, hormone receptor positive breast cancer in men and women, after surgery or chemotherapy to reduce recurrence risk, and for management of advanced stage or metastatic hormone-receptor positive breast cancer. Women at high risk of developing breast cancer also use Tamoxifen. Tamoxifen is at the maturity stage of product life cycle and is anticipated to experience decline in market growth in the light of introduction of advanced breast cancer management drugs.

This report analyzes the geographical distribution of tamoxifen market in North America, Europe, Asia-Pacific and Rest of the World markets. Currently, North America is the largest market for tamoxifen drugs and it is anticipated that the lead of this region will continue through 2022. Large pool of breast cancer patients, high awareness for breast cancer screening and prevention, well-structured reimbursement scenario and large pool of breast cancer patients. Asia-Pacific and Rest of the World markets will experience the fastest CAGR during 2016-2022. Improving awareness in Middle East and Africa, high incidence of late stage breast cancer in these regions and rapid development of healthcare infrastructure are the prime drivers of Rest of the World market.

Proven long-term efficiency of hormone therapy for management and control of breast cancer across various stages of treatment, in geriatric patients that cannot opt for surgery, and late-stage and recurrent breast cancer, and widespread use of tamoxifen as adjuvant therapy are the prime factors driving the demand for tamoxifen. Growth of tamoxifen-resistant cancer and growing awareness about the drug inducing endometrial cancer may restrain the market growth. Growing application of tamoxifen in treatment of conditions such as McCune-Albright syndrome, infertility, gynecomastia, bipolar disorder, angiogenesis and Riedel’s thyroiditis, and its use in research studies involving gene expression serve as future avenues for the growth of this market.

The global tamoxifen market is moderately competitive with AstraZaneca, Teva Pharmaceutical Industries, Allergan, Mylan, Apotex and Midatech the known players. Anticipated merger of Teva with Allergan is expected to bring a shift in market competition.

ToC:
Chapter 1 Preface
1.1 Report Description
1.1.1 Purpose of the Report
1.1.2 Target Audience
1.1.3 USP and Key Offerings
1.2 Research Scope
1.3 Research Methodology
1.3.1 Phase I – Secondary Research
1.3.2 Phase II – Primary Research
1.3.3 Phase III – Expert Panel Review
1.3.4 Assumptions

Chapter 2 Executive Summary

Chapter 3 Tamoxifen: Market Dynamics and Outlook
3.1 Introduction
3.2 Breast Cancer: Key Statistics
3.3 Major Events Assessment
3.4 Market Dynamics
3.4.1 Drivers
3.4.1.1 Advantages of Hormone Therapy Across Different Stages of Treatment
3.4.1.2 Widespread use as Adjuvant and Neo-Adjuvant Therapy
3.4.2 Challenges
3.4.2.1 Growth in Tamoxifen-Resistant Breast Cancer
3.4.3 Opportunities
3.4.3.1 Alternative uses of Tamoxifen
3.5 Attractive Investment Proposition
3.6 Market Positioning of Key Manufacturers.....

Browse Full Report: http://www.acutemarketreports.com/report/tamoxifen-market

Latest Reports: http://www.acutemarketreports.com/report/medical-gases-market-size
http://www.acutemarketreports.com/report/synthetic-lubricants-market-size

About Us:
Acute Market Reports is the most sufficient collection of market intelligence services online. It is your only source that can fulfill all your market research requirements. We provide online reports from over 100 best publishers and upgrade our collection regularly to offer you direct online access to the world’s most comprehensive and recent database with expert perceptions on worldwide industries, products, establishments and trends. Our database consists of 200,000+ market research reports with detailed & minute market research.

Company: http://www.acutemarketreports.com/

Media Contact
Company Name: Acute Market Reports
Contact Person: Chris Paul
Email: sales@acutemarketreports.com
Phone: Toll Free US/Canada: +1-855-455-8662
Address:105 N 1st ST #429, SAN JOSE, CA 95103
City: SANJOSE
State: CALIFORNIA
Country: United States

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Tamoxifen Market with Industry Size, Market aspect, and Forecast 2017-2025 Acute Market Reports here

News-ID: 924210 • Views:

More Releases from Acute Market Reports

Driving Innovation: The Evolving Landscape of the Diamond Substrate Market
The diamond substrate market, nestled within the semiconductor and electronics industry, is witnessing remarkable growth and transformation. With diamond as its cornerstone material, this specialized segment is powering advancements across high-frequency electronics, optoelectronics, high-power electronics, and even quantum computing. Valued at $111.8 million in 2023, this market is poised to soar to $331.6 million by 2032, exhibiting a robust CAGR of 12.90%. Access Complete Report From http://www.acutemarketreports.com/report/diamond-substrate-market At the heart of this
Clad Pipe Market | Global Industry Size, Development Strategy, Revenue Analysis, Top Leaders, Segmentation, Future Trends and Regional Forecast to 2031
Clad Pipe Market | Global Industry Size, Development Strategy, Revenue Analysis, …
The global market for clad pipe is projected to reach $3870.4 million by 2031, up from $2500 million in 2022, representing a CAGR of 5.10 percent over the period from 2023 to 2031. During the projected period of 2023 to 2031, it is anticipated that the market for clad pipes will exhibit a CAGR of 5.10%. A Clad Pipe is a form of steel pipe with a layer of corrosion-resistant
Explosion Proof Equipment Market 2031 | Global Industry Size, Development Strategy, Revenue Analysis, Top Leaders, Segmentation, Future Trends and Regional Forecast to 2031
Explosion Proof Equipment Market 2031 | Global Industry Size, Development Strate …
According to a new market research report published by Acute Market Reports, "Explosion Proof Equipment Market (by End-use Vertical (Oil & Gas, Industrial Manufacturing & Processing, Energy & Mining, Pharmaceuticals, and Other Verticals), by Applicable System Type (Material Handling Systems, Surveillance Systems, Power Supply Systems, Motors, Automation Systems, and Others), by Hazardous Zone (Zone 0, Zone 20, Zone 1, Zone 21, Zone 2, Zone 22), by Geography (North America, Europe,

More Releases for Tamoxifen

Tamoxifen Market Size, Share, Development by 2024
Global Info Research offers a latest published report on Tamoxifen Market Analysis and Forecast 2019-2025 delivering key insights and providing a competitive advantage to clients through a detailed report. The report contains 102 pages which highly exhibit on current market analysis scenario, upcoming as well as future opportunities, revenue growth, pricing and profitability. Click to view the full report TOC, figure and tables: https://www.globalinforesearch.com/global-tamoxifen-market_p199874.html   Scope of the Report: The worldwide market for Tamoxifen is
Tamoxifen Market - Size, and Opportunity Analysis 2018-2026
Tamoxifen is a type of selective estrogen receptor modulator (SERM) indicated for the treatment of women with high risk of breast cancer. Since its approval in 1998, tamoxifen has been used to treat millions of patients diagnosed with hormone receptor positive, early stage of breast cancer after surgery to reduce the risk of recurrence. It is the first choice for treatment of premenopausal women. Tamoxifen is the generic name for
Tamoxifen Market Drivers, Restraints, Opportunities, and Threats 2015 - 2025
Tamoxifen is an antagonist of the estrogen receptor in breast tissue. It is a selective estrogen-receptor modulator used in the treatment of breast cancer. Tomoxifen act as antagonist in mammary tissue but it act as agonist in other tissues like endometrium. Tamoxifen is indicated for the treatment of metastatic breast cancer in women and men. It is also used in ductal carcinoma treatment. Tamoxifen also used in the other treatments like
Tamoxifen Market to Register Substantial Expansion by 2025
Tamoxifen is an antagonist of the estrogen receptor in breast tissue. It is a selective estrogen-receptor modulator used in the treatment of breast cancer. Tomoxifen act as antagonist in mammary tissue but it act as agonist in other tissues like endometrium. Tamoxifen is indicated for the treatment of metastatic breast cancer in women and men. It is also used in ductal carcinoma treatment. Tamoxifen also used in the other treatments like
Tamoxifen Market Volume Analysis, size, share and Key Trends 2015 - 2025
Tamoxifen is an antagonist of the estrogen receptor in breast tissue. It is a selective estrogen-receptor modulator used in the treatment of breast cancer. Tomoxifen act as antagonist in mammary tissue but it act as agonist in other tissues like endometrium. Tamoxifen is indicated for the treatment of metastatic breast cancer in women and men. It is also used in ductal carcinoma treatment. Tamoxifen also used in the other treatments like
Tamoxifen Market Predicted to Witness Surge in the Near Future
Tamoxifen is an antagonist of the estrogen receptor in breast tissue. It is a selective estrogen-receptor modulator used in the treatment of breast cancer. Tomoxifen act as antagonist in mammary tissue but it act as agonist in other tissues like endometrium. Tamoxifen is indicated for the treatment of metastatic breast cancer in women and men. It is also used in ductal carcinoma treatment. Tamoxifen also used in the other treatments like